Cooper Financial Group Repligen Corp Transaction History

Cooper Financial Group

  • $752 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$148.08 - $206.57 $273,503 - $381,534
-1,847 Closed
0 $0
Q3 2020

Oct 09, 2020
BUY
$122.51 - $158.27 $2,327 - $3,007
19 Added 1.04%
1,847 $273,000
Q2 2020

Jul 15, 2020
BUY
$94.33 - $140.48 $172,435 - $256,797
1,828 New
1,828 $226,000

Others Institutions Holding RGEN

# of Institutions
487
Shares Held
54.4M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Cooper Financial Group Portfolio

Follow Cooper Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cooper Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Cooper Financial Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email